News

Find News

Filter articles

Showing 2361 to 2370 of 2458 results

Amici submit brief to support Ambry in Myriad case

US30-08-2013

The American Civil Liberties Union and other groups have submitted an amici curiae brief in support of Ambry Genetics and Gene by Gene in their patent infringement cases with Myriad Genetics Inc.

Marks & Clerk UK promotes two to partnership

UK28-08-2013

UK IP firm Marks & Clerk LLP has announced two of its attorneys will be joining the firm’s partnership.

Austria becomes first country to ratify Unified Patent Court agreement

Austria, EU27-08-2013

Austria has become the first country in the EU to ratify consent to the Unified Patent Court.

Miles & Stockbridge welcomes eight IP professionals

US23-08-2013

US law firm Miles & Stockbridge PC has continued the expansion of its IP practice with the addition of seven lawyers and one patent agent.

Eli Lilly bids to stop generics cutting Alimta exclusivity

US23-08-2013

Eli Lilly has begun its defence of a patent covering lung cancer drug Alimta against generic companies including Teva, Barr Laboratories and APP Pharmaceuticals.

Horizon Pharma settles Duexis case with Par Pharmaceuticals

US22-08-2013Legal developments

US-based Horizon Pharma Inc agreed on August 22 to settle its patent dispute over arthritis drug Duexis with generic maker Par Pharmaceutical Companies.

Roche relinquishes patent on breast cancer drug

India19-08-2013

Drugmaker Roche has decided not to pursue a patent application for a breast cancer drug in the Indian market, enabling rivals to possibly produce cheaper versions.

Allergan sued over breast implant patent

US14-08-2013

Texas-based Almha has launched patent infringement lawsuits against four companies, including UK company Allergan, in relation to its patent covering a “breast implant with position lock”.

Sheppard Mullin hires partner in California

US14-08-2013

Lorna Tanner has joined the Palo Alto office of Sheppard Mullin Richter & Hampton LLP as an IP partner.

SIPO pulls Viread patent – victory for pharma innovators?

China13-08-2013

The Chinese State Intellectual Property Office (SIPO) has revoked a patent covering biopharmaceutical company Gilead Science’s HIV drug Viread, Reuters subsidiary news site BioWorld reported.

Showing 2361 to 2370 of 2458 results

LSIPR